Advertising
Advertising
twitter
youtube
facebook
instagram
linkedin
Advertising

GPW’s Analytical Coverage Support Programme 3.0

GPW’s Analytical Coverage Support Programme 3.0

The Warsaw Stock Exchange's (GPW's) Analytical Coverage Support Programme 3.0 supports investment firms in drafting analytical reports which are financed by GPW. The objective of the Programme is to improve the availability of research covering less liquid companies, facilitating investors' informed investment decisions based on a reliable independent source of issuer information. Eligible to participate in the Programme are companies listed on the GPW Main Market (other than WIG20 participants) and on NewConnect. The Programme covers up to 50 issuers.

Twitter | LinkedIn 


Author's articles

Q3'23 EBITDA Misses Expectations; 2023-26 Strategy Unveiled by Company

Q3'23 EBITDA Misses Expectations; 2023-26 Strategy Unveiled by Company

FOREX
GPW’s Analytical Coverage Support Programme 3.0
BDM Q3'23 Report: Revenue Decline and Increased Operating Expenses Raise Concern

BDM Q3'23 Report: Revenue Decline and Increased Operating Expenses Raise Concern

FOREX
GPW’s Analytical Coverage Support Programme 3.0
Artifex Q3'23 Report: Robust Financial Performance and Strategic Game Development Initiatives

Artifex Q3'23 Report: Robust Financial Performance and Strategic Game Development Initiatives

FOREX
GPW’s Analytical Coverage Support Programme 3.0
Artifex Q3'23 Results Review: Meeting Expectations with Neutral Outlook

Artifex Q3'23 Results Review: Meeting Expectations with Neutral Outlook

FOREX
GPW’s Analytical Coverage Support Programme 3.0
Artifex Q3'23 Results: Revenue Growth, Improved Profitability, and Future Game Development Plans

Artifex Q3'23 Results: Revenue Growth, Improved Profitability, and Future Game Development Plans

FOREX
GPW’s Analytical Coverage Support Programme 3.0
Positive Developments in Kardiolytics: VCAST Certification and Strategic Partnerships Fuel Optimism for Future Growth

Positive Developments in Kardiolytics: VCAST Certification and Strategic Partnerships Fuel Optimism for Future Growth

FOREX
GPW’s Analytical Coverage Support Programme 3.0
Navigating Mixed Signals: Update on Medicalgorithmics' ECG Business Outlook

Navigating Mixed Signals: Update on Medicalgorithmics' ECG Business Outlook

FOREX
GPW’s Analytical Coverage Support Programme 3.0
BacterOMIC Set to Enter Partnering Phase: Scope Fluidics Receives BUY Rating with FV at PLN 230.2ps

BacterOMIC Set to Enter Partnering Phase: Scope Fluidics Receives BUY Rating with FV at PLN 230.2ps

FOREX
GPW’s Analytical Coverage Support Programme 3.0
Preliminary 3Q23 Financial Results: Action Reports NP in Line with Forecasts

Preliminary 3Q23 Financial Results: Action Reports NP in Line with Forecasts

FOREX
GPW’s Analytical Coverage Support Programme 3.0
DataWalk Secures New Contract with Polaris Wireless Amid Investors TFI Share Disposal

DataWalk Secures New Contract with Polaris Wireless Amid Investors TFI Share Disposal

FOREX
GPW’s Analytical Coverage Support Programme 3.0
Miraculum's 3Q23 Results Surpass Expectations with Strong EBITDA and Improved Gross Margin

Miraculum's 3Q23 Results Surpass Expectations with Strong EBITDA and Improved Gross Margin

FOREX
GPW’s Analytical Coverage Support Programme 3.0
Tight Sales and Ongoing Market Challenges: A Review of Q4'23 Results and Future Capacity Expansion

Tight Sales and Ongoing Market Challenges: A Review of Q4'23 Results and Future Capacity Expansion

FOREX
GPW’s Analytical Coverage Support Programme 3.0
Analysis of 3Q23 Results: Gross Profit Decline, Operating Expenses, and Receivable Challenges

Analysis of 3Q23 Results: Gross Profit Decline, Operating Expenses, and Receivable Challenges

FOREX
GPW’s Analytical Coverage Support Programme 3.0
3Q23 Revenues Report: Bioton Sees a 12% YoY Decline, Driven by Insulin Sales Drop of 18%

3Q23 Revenues Report: Bioton Sees a 12% YoY Decline, Driven by Insulin Sales Drop of 18%

FOREX
GPW’s Analytical Coverage Support Programme 3.0
Bioton's 3Q23 Financial Performance: Below Expectations with Production Downtime Impact

Bioton's 3Q23 Financial Performance: Below Expectations with Production Downtime Impact

FOREX
GPW’s Analytical Coverage Support Programme 3.0
Analytical Insight: ZUE Q3'23 Preliminary Results and BDM's Recommendations

Analytical Insight: ZUE Q3'23 Preliminary Results and BDM's Recommendations

FOREX
GPW’s Analytical Coverage Support Programme 3.0
XTPL Preliminary Q3’23 Sales: Steady Performance with PLN 3.7m Revenue

XTPL Preliminary Q3’23 Sales: Steady Performance with PLN 3.7m Revenue

FOREX
GPW’s Analytical Coverage Support Programme 3.0
Mabion 3Q23 Earnings Forecast: Positive EBIT Amid Shutdown, Revenue Projection at PLN 25 Million

Mabion 3Q23 Earnings Forecast: Positive EBIT Amid Shutdown, Revenue Projection at PLN 25 Million

FOREX
GPW’s Analytical Coverage Support Programme 3.0
Q3'23 Anticipation: Navigating Through Seasonal Challenges in Photovoltaic Projects

Q3'23 Anticipation: Navigating Through Seasonal Challenges in Photovoltaic Projects

FOREX
GPW’s Analytical Coverage Support Programme 3.0
Robust Omnichannel Sales Drive Q3'23 Revenue Surge, Profits Impacted by Development Costs

Robust Omnichannel Sales Drive Q3'23 Revenue Surge, Profits Impacted by Development Costs

FOREX
GPW’s Analytical Coverage Support Programme 3.0
<
1

...

67
8
910

...

28
>